BioCentury
ARTICLE | Company News

MRC Technology, University of Lausanne deal

October 19, 2015 7:00 AM UTC

MRC Technology and the university partnered to develop small molecules inhibitors of mucosa associated lymphoid tissue lymphoma translocation protein 1 ( MALT1) to treat diffuse large B cell lymphoma....